The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus

被引：0
|
作者：
Fanhuan Xu
Jiacheng Jin
Juan Guo
Feng Xu
Jianan Chen
Qi Liu
Luxi Song
Zheng Zhang
Liyu Zhou
Jiying Su
Chao Xiao
Yumei Zhang
Meng Yan
Qi He
Dong Wu
Chunkang Chang
Xiao Li
Lingyun Wu
机构：
[1] Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Department of Hematology
[2] Shanghai Jiao Eighth People’s Hospital,Department of Hematology
来源：
Journal of Cancer Research and Clinical Oncology | / 150卷
关键词：
Myelodysplastic syndromes; Diabetes mellitus; Gene mutation; Prognosis; Infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Clinical characteristics and outcomes of empyema thoracis amongst patients with diabetes mellitus
    Shu-Leung, Kevin
    Lee, Lai Kai-Ling
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [32] Combining gene variants with clinical characteristics improves outcome prediction in Chinese patients with myelodysplastic syndromes
    Yu, Yan
    Zhang, Tongtong
    Bao, Xiebing
    Wang, Qinrong
    Zhang, Ling
    Hong, Yang
    Zeng, Zhao
    Shen, Hongjie
    Wu, Depei
    Pan, Jinlan
    Liu, Hong
    Chen, Suning
    Sun, Aining
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 919 - 926
  • [33] The Clinical, Cytogenetic and Risk Features of Myelodysplastic Syndromes with no Detectable Somatic Mutations
    Wang, Sa
    Thakral, Beenu
    Morgan, Elizabeth
    Patel, Sanjay
    Nardi, Valentina
    Patel, Keyur
    Weinberg, Olga
    Hasserjian, Robert
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1403 - 1403
  • [34] Diabetes mellitus with mitochondrial gene mutations in Japan
    Suzuki, S
    MITOCHONDRIAL PATHOGENESIS: FROM GENES AND APOPTOSIS TO AGING AND DISEASE, 2004, 1011 : 185 - 192
  • [35] Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes
    Naoki Shingai
    Yuka Harada
    Hiroko Iizuka
    Yosuke Ogata
    Noriko Doki
    Kazuteru Ohashi
    Masao Hagihara
    Norio Komatsu
    Hironori Harada
    International Journal of Hematology, 2018, 108 : 598 - 606
  • [36] The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
    Zhang, Ling
    Padron, Eric
    Lancet, Jeffrey
    LEUKEMIA RESEARCH, 2015, 39 (01) : 6 - 17
  • [37] Mitochondrial gene mutations in gestational diabetes mellitus
    Chen, Y
    Liao, WX
    Roy, AC
    Loganath, A
    Ng, SC
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 48 (01) : 29 - 35
  • [38] Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes
    Shingai, Naoki
    Harada, Yuka
    Iizuka, Hiroko
    Ogata, Yosuke
    Doki, Noriko
    Ohashi, Kazuteru
    Hagihara, Masao
    Komatsu, Norio
    Harada, Hironori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (06) : 598 - 606
  • [39] The Clinical, Cytogenetic and Risk Features of Myelodysplastic Syndromes with no Detectable Somatic Mutations
    Wang, Sa
    Thakral, Beenu
    Morgan, Elizabeth
    Patel, Sanjay
    Nardi, Valentina
    Patel, Keyur
    Weinberg, Olga
    Hasserjian, Robert
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1403 - 1403
  • [40] Myelodysplastic Syndromes without Detectable Mutations: Analysis of Clinical Presentation and Outcome
    Bataller, Alex
    Kanagal-Shamanna, Rashmi
    Chien, Kelly S.
    Montalban-Bravo, Guillermo
    Kadia, Tapan M.
    Ravandi, Farhad
    DiNardo, Courtney D.
    Daver, Naval
    Short, Nicholas
    Borthakur, Gautam
    Jabbour, Elias
    Hammond, Danielle
    Masarova, Lucia
    Ganan-Gomez, Irene
    Adema, Vera
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Sasaki, Koji
    BLOOD, 2022, 140 : 9793 - 9795
12345